According to a survey of treatment-related severe hypoglycemia conducted by the JDS, more than 90% of Japanese patients with T2DM who experienced severe hypoglycemia were being treated with insulin and/or sulfonylureas (23). This evidence concerns the gene INS and Hypoglycemia.